134 related articles for article (PubMed ID: 8204468)
1. Improved prediction of the minimal phototoxic dose in PUVA therapy.
Sakuntabhai A; Matthews JN; Farr PM
Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
[TBL] [Abstract][Full Text] [Related]
2. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
Al-Ismail D; Edwards C; Anstey AV
Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
[TBL] [Abstract][Full Text] [Related]
3. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
[TBL] [Abstract][Full Text] [Related]
5. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
[TBL] [Abstract][Full Text] [Related]
6. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
Bech-Thomsen N; Angelo HR; Wulf HC
Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
[TBL] [Abstract][Full Text] [Related]
7. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
[TBL] [Abstract][Full Text] [Related]
8. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Sakuntabhai A; Farr PM; Diffey BL
Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
[TBL] [Abstract][Full Text] [Related]
9. Psoralen-ultraviolet A-induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid.
Yeo UC; Shin JH; Yang JM; Park KB; Kim MM; Bok HS; Lee ES
Br J Dermatol; 2000 Apr; 142(4):733-9. PubMed ID: 10792224
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of PUVA bath phototoxicity.
Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
[TBL] [Abstract][Full Text] [Related]
11. The relationship between plasma psoralen concentration and psoralen-UVA erythema.
Mclelland J; Fisher C; Farr PM; Diffey BL; Cox NH
Br J Dermatol; 1991 Jun; 124(6):585-90. PubMed ID: 2064944
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy.
Smith G; Wilkie MJ; Deeni YY; Farr PM; Ferguson J; Wolf CR; Ibbotson SH
Br J Dermatol; 2007 Dec; 157(6):1230-4. PubMed ID: 17916200
[TBL] [Abstract][Full Text] [Related]
13. The influence of food on 8-methoxypsoralen serum concentration and minimal phototoxic dose.
Bech-Thomsen N; Angelo HR; Knudsen EA
Br J Dermatol; 1992 Dec; 127(6):620-4. PubMed ID: 1476921
[TBL] [Abstract][Full Text] [Related]
14. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.
Ljunggren B; Bjellerup M; Carter DM
J Invest Dermatol; 1981 Feb; 76(2):73-5. PubMed ID: 7462679
[TBL] [Abstract][Full Text] [Related]
15. The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion.
Man I; Kwok YK; Dawe RS; Ferguson J; Ibbotson SH
Arch Dermatol; 2003 Mar; 139(3):331-4. PubMed ID: 12622625
[TBL] [Abstract][Full Text] [Related]
16. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
[TBL] [Abstract][Full Text] [Related]
17. The time course of phototoxicity of topical PUVA: 8-methoxypsoralen cream-PUVA vs. 8-methoxypsoralen gel-PUVA.
Grundmann-Kollmann M; Leiter U; Behrens S; Gottlöber P; Mooser G; Krähn G; Kerscher M
Br J Dermatol; 1999 May; 140(5):988-90. PubMed ID: 10354061
[No Abstract] [Full Text] [Related]
18. Calculation of 8-methoxypsoralen dose according to body surface area in PUVA treatment.
Sakuntabhai A; Diffey BL; Farr PM
Br J Dermatol; 1995 Dec; 133(6):919-23. PubMed ID: 8547045
[TBL] [Abstract][Full Text] [Related]
19. Phototesting and phototoxic side effects in bath PUVA.
Calzavara-Pinton PG; Ortel B; Carlino AM; Honigsmann H; De Panfilis G
J Am Acad Dermatol; 1993 Apr; 28(4):657-9. PubMed ID: 8463475
[No Abstract] [Full Text] [Related]
20. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy.
Ibbotson SH; Dawe RS; Dinkova-Kostova AT; Weidlich S; Farr PM; Ferguson J; Wolf CR; Smith G
Br J Dermatol; 2012 Feb; 166(2):380-8. PubMed ID: 21967523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
